Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Dow
Moodys
AstraZeneca
Express Scripts

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Technetium tc-99m teboroxime kit - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for technetium tc-99m teboroxime kit and what is the scope of freedom to operate?

Technetium tc-99m teboroxime kit is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Technetium tc-99m teboroxime kit has ten patent family members in seven countries.

There are four drug master file entries for technetium tc-99m teboroxime kit.

Summary for technetium tc-99m teboroxime kit
International Patents:10
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 4
DailyMed Link:technetium tc-99m teboroxime kit at DailyMed

US Patents and Regulatory Information for technetium tc-99m teboroxime kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CARDIOTEC technetium tc-99m teboroxime kit INJECTABLE;INJECTION 019928-001 Dec 19, 1990 DISCN No No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for technetium tc-99m teboroxime kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco CARDIOTEC technetium tc-99m teboroxime kit INJECTABLE;INJECTION 019928-001 Dec 19, 1990   Start Trial   Start Trial
Bracco CARDIOTEC technetium tc-99m teboroxime kit INJECTABLE;INJECTION 019928-001 Dec 19, 1990   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for technetium tc-99m teboroxime kit

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1178838 300736 Netherlands   Start Trial PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Moodys
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.